Before a prostate cancer patient makes a final decision to have focal laser ablation, I go over the details of MRI-guided FLA and what to expect after treatment. I always point out that there we do not yet have long-term data on the success rates as far as cancer control, so we don’t know how keep reading
An international team of experts on imaging prostate cancer participated in a review of the literature on prostate MRI and active surveillance.[i] To give you an idea of how impressive the team was, here is a list of the institutions they represent: Erasmus University Medical Center (Depts. of Urology and Radiology), Rotterday, the Netherlands University keep reading
Sadly, prostate cancer (PCa) patients with low-risk disease are still being sent for needless diagnostic bone and CT scans. This was the finding of an impressive multi-disciplinary research team from several institutions (U.S. Veterans Administration and various medical and public policy departments within New York University and Yale University). The investigators found that nearly keep reading
“There is increased use of radiotherapy among patients with indolent prostate cancer with limited to no correlation with tumor biology.” This conclusion was reached by a research team out of UCLA after studying the treatment choices of 37,621 patients.[i] In fact, over half (57.9%) of the men were sent for radiation, while 19.1% had a keep reading
It’s always affirming to find peer-reviewed data that confirms my professional experience, convictions, and commitment to patients. A newly published study based on over 1800 men reveals some hard facts about the incidence of repeat biopsies, and how unproductive they often are. The study is out of New York University (NYU).[i] The authors reviewed the keep reading
